Trial intelligence / Profile preview

Combined obturator and femoral nerve block vs femoral nerve block alone for preoperative analgesia in hip fracture

2015-002304-89Phase 4Terminated

Sponsor
Thomas Fichtner Bendtsen
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of bupivacaine in hip fracture and Neck Of Femur Fracture (2 arms), sponsored by Thomas Fichtner Bendtsen. Primary endpoint: Success rate of analgesic effect at 30 minutes. Started Jun 2015; status: terminated.

02

Drugs

bupivacaine
03

Conditions

hip fractureNeck Of Femur Fracture

Beyond the preview

Go deeper on 2015-002304-89.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002304-89.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call